Adam Nogalski, MD, PhD
In the Clinic of Trauma Surgery of the Medical University of Lublin, between April 2013 and February 2014, five patients were operated on with the use of the bone substitute material created and patented by the Department of Biochemistry of the Medical University of Lublin. All these patients had post-traumatic bone losses and disturbances of bone union. No abnormalities, allergic reactions, symptoms of infection or other complications were observed in post-surgery examinations. To sum up, the results of the treatment with this bone-replacement material are promising and it seems to be safe and easy to implant.
Department of Trauma Surgery and Emergency Medicine, Medical University of Lublin
The medicine Dariusz Bojanowski
A great advantage of the material is that it can be soaked with medicines in order to obtain local effects (antibiotics). The time of release of the medicines can be indicated as an element of competitive advantage of the biocomposite.
Head of the Department of Trauma and Orthopaedic Surgery of the Our Lady of Perpetual Help Hospital in Wołomin
Prof. Romuald Będziński, PhD. Eng.
Professor Będziński called the MI biomaterial a 'potential hit’. According to the professor, currently used porous ceramic materials are hard and brittle, and the integration with the patient's bone is not complete. According to Professor Będziński, the biomaterial can be used on the 'profitable' market of aesthetic surgery. Professor Będziński expressed his opinion that physicians should not have any reservations on the use of MI biomaterial, because they care about the best possible effects of the procedures carried out, so if the product works well, it should be of interest to specialists.
Department of Biomedical Engineering and Experimental Mechanics, Wrocław University of Science and Technology
Prof. h.c. Kazimierz Kobus, MD, PhD.
In the Professor's opinion, if the above mentioned features and, first of all, the flexibility and ability to align to the cavity (by filling it in) prove to be true after clinical trials, the product should generate demand on the market.
Plastic Surgery Department, SCM Polanica Zdrój